M P Bazylewicz

Suggest Changes
Learn More
644.<lb>8. Schulz H, Rehwald U, Morschhauser F, et al. Rituximab in relapsed lympho-<lb>cyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the<lb>German Hodgkin Lymphoma Study(More)
  • 1